Share “News Summary: Amgen 4Q profit drops, costs...”

News Summary: Amgen 4Q profit drops, costs rise

Published on NewsOK Modified: January 23, 2013 at 7:51 pm •  Published: January 23, 2013
Advertisement

PROFIT SLUMP: Biotech giant Amgen Inc.'s fourth-quarter net income dropped 16 percent to $788 million, or $1.01 per share, due to higher spending on production, marketing, research and other items.

SALES SURGE: Revenue rose 11 percent to $4.42 billion, as sales of immune disorder treatment Enbrel and four other drugs climbed by double digits. But part of the revenue jump was due to price increases.

2013 FORECASTS: Amgen's forecast is for earnings per share of $6.85 to $7.15. It expects revenue of $17.8 billion to $18.2 billion — about the level it previously forecast for 2015.


AROUND THE WEB

  1. 1
    It's back: FEC says regulating Internet, Google, Facebook under its 'purview'
  2. 2
    Lawyers offered to pay this street band to stop playing. It said ‘no.’
  3. 3
    Nancy Lieberman calls becoming Kings assistant a 'Crazy, wonderful day'
  4. 4
    Report: Russell Wilson, Seahawks agree to 4-year, $87.6 million extension
  5. 5
    Dez Bryant says $70 million deal 'no pressure'
+ show more

FEATURED JOBS



× Trending business Article